Rubén Darío Castro-Torres

Dr. Rubén Darío Castro-Torres

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
OFOriol Busquets Figueras
Oriol Busquets Figueras
MEMiren Ettcheto
Miren Ettcheto
ACAmanda Cano
Amanda Cano
PMPatricia R. Manzine
Patricia R. Manzine
Elena Sánchez LópezElena Sánchez López
Elena Sánchez López
Antoni CaminsAntoni Camins
Antoni Camins
Previous studies have reported that the regulatory function of the different c-Jun N-terminal kinases isoforms (JNK1, JNK2, and JNK3) play an essential role in neurological disorders, such as epilepsy and metabolic-cognitive alterations. Accordingly, JNKs have emerged as suitable therapeutic strategies. In fact, it has been demonstrated that some unspecific JNK inhibitors exert antidiabetic and neuroprotective effects, albeit they usually show high toxicity or lack therapeutic value. In this sense, natural specific JNK inhibitors, such as Licochalcone A, are promising candidates. Nonetheless, research on the understanding of the role of each of the JNKs remains mandatory in order to progress on the identification of new selective JNK isoform inhibitors. In the present review, a summary on the current gathered data on the role of JNKs in pathology is presented, as well as a discussion on their potential role in pathologies like epilepsy and metabolic-cognitive injury. Moreover, data on the effects of synthetic small molecule inhibitors that modulate JNK-dependent pathways in the brain and peripheral tissues is reviewed.

13 August 2020 in Cells
Verified
Journal Article
Open access
PDF file
RCRubén Darío Castro-Torres
Rubén Darío Castro-Torres
OFOriol Busquets Figueras
Oriol Busquets Figueras
APAntoni Parcerisas
Antoni Parcerisas
EVEster Verdaguer
Ester Verdaguer
JOJordi Olloquequi
Jordi Olloquequi
CACarme Auladell
Carme Auladell
The c-Jun N-terminal Kinases (JNKs) are a group of regulatory elements responsible for the control of a wide array of functions within the cell. In the central nervous system (CNS), JNKs are involved in neuronal polarization, starting from the cell division of neural stem cells and ending with their final positioning when migrating and maturing. This review will focus mostly on isoform JNK1, the foremost contributor of total JNK activity in the CNS. Throughout the text, research from multiple groups will be summarized and discussed in order to describe the involvement of the JNKs in the different steps of neuronal polarization. The data presented support the idea that isoform JNK1 is highly relevant to the regulation of many of the processes that occur in neuronal development in the CNS.

6 March 2020 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
RCRubén Darío Castro-Torres
Rubén Darío Castro-Torres
MUMónica E. Ureña-Guerrero
Mónica E. Ureña-Guerrero
LCLilia Morales Chacon
Lilia Morales Chacon
LLLourdes Lorigados
Lourdes Lorigados
BDBárbara O. Estupiñan Díaz
Bárbara O. Estupiñan Díaz
CBCarlos Beas-Zarate
Carlos Beas-Zarate

Verified
Journal Article
Open access
PDF file
RCRubén Darío Castro-Torres
Rubén Darío Castro-Torres
JOJordi Olloquequi
Jordi Olloquequi
MEMiren Ettcheto
Miren Ettcheto
PCPablo Caruana
Pablo Caruana
LSLuke Steele
Luke Steele
CACarme Auladell
Carme Auladell
(1) Background: The c-Jun-NH2-terminal protein kinase (JNK) is a mitogen-activated protein kinase involved in regulating physiological processes in the central nervous system. However, the dual genetic deletion of Mkk4 and Mkk7 (upstream activators of JNK) in adult mice is not reported. The aim of this study was to induce the genetic deletion of Mkk4/Mkk7 in adult mice and analyze their effect in hippocampal neurogenesis. (2) Methods: To achieve this goal, Actin-CreERT2 (Cre+/−), Mkk4flox/flox, Mkk7flox/flox mice were created. The administration of tamoxifen in these 2-month-old mice induced the gene deletion (Actin-CreERT2 (Cre+/−), Mkk4∆/∆, Mkk7∆/∆ genotype), which was verified by PCR, Western blot, and immunohistochemistry techniques. (3) Results: The levels of MKK4/MKK7 at 7 and 14 days after tamoxifen administration were not eliminated totally in CNS, unlike what happens in the liver and heart. These data could be correlated with the high levels of these proteins in CNS. In the hippocampus, the deletion of Mkk4/Mkk7 induced a misalignment position of immature hippocampal neurons together with alterations in their dendritic architecture pattern and maturation process jointly to the diminution of JNK phosphorylation. (4) Conclusion: All these data supported that the MKK4/MKK7–JNK pathway has a role in adult neurogenic activity.

Verified
Journal Article
Open access
PDF file
NGNidia Jannette Carrillo González
Nidia Jannette Carrillo González
GGGabriela Stefania Reyes Gutierrez
Gabriela Stefania Reyes Gutierrez
TCTania Campos-Ordonez
Tania Campos-Ordonez
RCRubén Darío Castro-Torres
Rubén Darío Castro-Torres
CBCarlos Beas-Zarate
Carlos Beas-Zarate
GCGraciela Gudiño Cabrera
Graciela Gudiño Cabrera
Olfactory ensheathing cells (OECs) and mesenchymal stem cells (MSCs) differentiated towards Schwann-like have plasticity properties. These cells express the Glial fibrillary acidic protein (GFAP), a type of cytoskeletal protein that significantly regulates many cellular functions, including those that promote cellular plasticity needed for regeneration. However, the expression of GFAP isoforms (α, β, and δ) in these cells has not been characterized. We evaluated GFAP isoforms (α, β, and δ) expression by Polymerase Chain Reaction (PCR) assay in three conditions: (1) OECs, (2) cells exposed to OECs-conditioned medium and differentiated to Schwann-like cells (dBM-MSCs), and (3) MSC cell culture from rat bone marrow undifferentiated (uBM-MSCs). First, the characterization phenotyping was verified by morphology and immunocytochemistry, using p75, CD90, and GFAP antibodies. Then, we found the expression of GFAP isoforms (α, β, and δ) in the three conditions; the expression of the GFAPα (10.95%AUC) and GFAPβ (9.17%AUC) isoforms was predominantly in OECs, followed by dBM-MSCs (α: 3.99%AUC, β: 5.66%AUC) and uBM-MSCs (α: 2.47%AUC, β: 2.97%AUC). GFAPδ isoform has a similar expression in the three groups (OEC: 9.21%AUC, dBM-MSCs: 11.10%AUC, uBM-MSCs: 9.21%AUC). These findings suggest that expression of different GFAPδ and GFAPβ isoforms may regulate cellular plasticity properties, potentially contributing to tissue remodeling processes by OECs, dBM-MSCs, and uBM-MSCs.

5 July 2020 in Mexican Journal of Medical Research ICSA
Verified
Journal Article
Open access
PDF file
CACarme Auladell
Carme Auladell
RCRubén Darío Castro-Torres
Rubén Darío Castro-Torres
OFOriol Busquets Figueras
Oriol Busquets Figueras
MEMiren Ettcheto
Miren Ettcheto
Antoni CaminsAntoni Camins
Antoni Camins
EVEster Verdaguer
Ester Verdaguer
In mammals, the term “adult hippocampal neurogenesis” defines the process through which, throughout adulthood, new granular neurons are produced by neural stem cells (NSC) in the subgranular zone (SGZ) in the dentate gyrus (DG) of the hippocampus or, by a population of immature neurons located in the SGZ. Either way, the existence of neurogenic activity in the hippocampus has been correlated with learning, memory formation and behavioral responses to stress, together with the pathophysiology of many brain diseases and mood disorders. Various extracellular and intracellular stimuli have been shown to modulate survival, proliferation, and differentiation of adult-born cells in the hippocampus especially, through conserved stimuli-response mechanisms like the JNKs, which have been described as regulators of adult neurogenesis. In the present review, the JNK pathway and their control of adult hippocampal neurogenesis is described, evidencing the critical role of JNK1 in this process.